Skip to main content
. Author manuscript; available in PMC: 2017 Dec 30.
Published in final edited form as: Transl Res. 2015 Jun 9;167(1):80–87. doi: 10.1016/j.trsl.2015.06.001

Table 1.

Summary of recently described clinical associations and tissue expression of angiogenic factors in aGVHD.

Angiogenic
Factor
Circulating
Level in aGVHD
Clinical Associations Cellular/Tissue
Expression in aGVHD
EGF Low Decreases in patients with no response to steroids at day 28 Unknown
VEGF-A Low Increases in patients with complete response to steroids at day 28 Megakaryocytes, likely others
PlGF High Highest in patients with aGVHD after HCT from unrelated donors compared to sibling donors Increased in aGVHD skin, decreased in aGVHD colon compared to normal controls
FS High Elevated levels associated with mortality at 6 months Unknown